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Pevelopmental Aspects of Long QT
yndrome Type 3 and Brugada Syndrome on the
asis of a Single SCN5A Mutation in Childhood
ertie C. M. Beaufort-Krol, MD, PHD,* Maarten P. van den Berg, MD, PHD,†
rthur A. M. Wilde, MD, PHD,‡ J. Peter van Tintelen, MD,§ Jan Willem Viersma, MD, PHD,†
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OBJECTIVES The aim was to investigate at what age electrocardiographic characteristics of long QT
syndrome type 3 (LQT3) and Brugada syndrome (BS), based on a single SNC5A mutation,
appear.
BACKGROUND The QT interval (QT) in LQT3 is prolonged during bradycardia. It is not clear yet if this is
obvious in young children with a relative fast heart rate (HR).
METHODS Thirty-six children with an SNC5A gene mutation (1795insD) and 46 non-carrier siblings
were investigated. In different age groups, HR, QT, QTc, and ST-segment elevation on a
12-lead electrocardiogram (ECG), and HR, QT, QTc, and QT after the longest pause in
a Holter (recording) were evaluated.
RESULTS In all age groups, HR at rest tended to be lower in carriers than in non-carriers, and QT was
longer in carriers than in non-carriers. The Brugada phenotype was found 5 years. Gender
specific differences were not identified. The QT at lower HR and QT were longer in carriers
than in non-carriers. A QTc of0.44 s at the lowest HR (sensitivity 100%; specificity 88.4%)
and QT 60 ms (sensitivity 100%; specificity 82.6%) were good predictors for having
LQT3.
CONCLUSIONS We conclude that electrocardiographic characteristics of LQT3 and BS show age-dependent
penetrance. A QT prolongation and conduction disease were present from birth onwards,
whereas ST-segment elevation only developed 5 years. Good tools for clinical diagnosis of
LQT3 in this family are QTc at the lowest HR and QT after a pause in a Holter, even at
very young age. (J Am Coll Cardiol 2005;46:331–7) © 2005 by the American College of






















dhe QT interval (QT) in congenital long QT syndrome
ype 3 (LQT3) is disproportionally prolonged during bra-
ycardia (1). Mutations in the cardiac sodium channel gene
CN5A are responsible for LQT3 (2), Brugada syndrome
BS) (3), and isolated cardiac conduction disease (4–6). We
ecently described a large eight-generation family with
200 adults characterized by premature nocturnal sudden
eath, LQT3, and BS (7). The underlying genetic defect
as a mutation in SCN5A (TGA insertion at position 5537
eading to the insertion of aspartic acid (1795insD) within
he C-terminal domain) (6,7).
In LQT3, symptoms generally occur after puberty (8,9),
nd in BS, the electrophysiological phenotype is most
revalent in the third decade. In both syndromes, male
ubjects seem to be at increased risk (10,11). In our family,
e followed children, some shortly after birth, to investigate
everal clinical parameters in relation to age, gender, and
enotype. The aim of the study was to establish the age of
nset of the electrocardiogram (ECG) patterns of LQT3
nd BS.
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atients. We included all but four (refusal of genetic
valuation) children (age 16 years) from this family, who
ere genetically proven to be carrier or non-carrier of the
795insD SCN5A mutation. All parents and children 12
ears provided written informed consent for clinical and
enetic evaluation. Data were collected between 1965 and
002 and in different age groups (0 to 1, 1 to 3, 3 to 5, 5 to
, 8 to 12, and 12 to 16 years). Since the genetic analysis
year 2000), the children could be divided into carriers and
on-carriers.
onitoring parameters. The children were evaluated by
istory, ECG (12-lead), Holter recording (Holter), ergom-
try, and signal-averaged electrocardiogram (SAECG).
In the ECG (supine position), heart rate (HR [beats/
in]), PQ interval (PQ [ms]), QRS width (ms), occurrence
f right bundle branch block (RBBB) (rSR= 90 at 4
ears; 100 at 4 years), J waves (rounded second wave of
RS interval), ST-segment elevation (1 mm in V1, V2, or
E [under xiphoid bone]; measured 40 ms after the
-point), QT, and QTc (ms; lead II; Bazett [12]) were
valuated.
In the Holter, mean, lowest, and highest HR, QT at
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Long QT3/Brugada Syndrome in Children July 19, 2005:331–7pause was defined as an R-R that was 50% longer than
he preceding R-R; Fig. 1), longest R-R, AV conduction,
nd rhythm disturbances were analyzed. All parameters in
CG and Holter before pacemaker implantation were eval-
ated at least every three years.
During ergometry (8 years; bicycle test), HR at rest,
xercise, and recovery, and QT at different HR were
easured (13).
In SAECG (5 years; 40 Hz), QRS interval width (ms),
40 (ms; time in which the voltage40 V at end of QRS
nterval), V40 (V; root mean square voltage for terminal 40
s of QRS interval), and late potentials (LP) were mea-
ured (14).
tatistical analysis. Data are expressed as mean  SD. A
wo-tailed Student t test for unpaired samples (with equal or
nequal variances, determined with F-ratio testing) or Fisher
xact test was performed. A p  0.05 was considered statis-
ically significant. Sensitivity and specificity of QTc and
QT were calculated with the 2  2 method for determin-
ng predictive values of a diagnostic test.
ESULTS
atient characteristics/history. Mean age at first visit was
.1  5.0 for carriers (n  36; 21 boys and 15 girls) and 5.9
2.1 years for non-carriers (n  46; 24 boys and 22 girls).
one of the carriers had complaints; they only came to our
ttention because of identification of the disorder in one of
he parents. Total follow-up period for carriers and non-
arriers was 9.6  9.3 years versus 10.8  7.2 years.
ollow-up period until pacemaker implantation (n  30; 5
AI, 14 VVI, 11 DDI) for carriers was 3.6  5.9 years.
uring follow-up, no sudden death occurred.
CG. In all age groups, HR at rest tended to be lower in
arriers than in non-carriers, but was within the normal
Abbreviations and Acronyms
AP  action potential
BS  Brugada syndrome
ECG  electrocardiogram
HR  heart rate
Ito  transient outward current
LQT3  long QT syndrome type 3
SAECG  signal-averaged electrocardiogram8
igure 1. QTQT interval after the longest pause in a Holter recording
inus QT of the preceding QRS interval (B  A).ange for age (Table 1) (15). The PQ was not different
etween carriers and non-carriers (data not shown). The
RS width was mostly longer in carriers (Table 1). We
ound no signs of RBBB or J waves in either group. The QT
as longer in carriers in every age group (Fig. 2A). Similar
esults were found for QTc; QTc in carriers increased with
ge (0.39  0.02 s at 0 to 1 year vs. 0.49  0.06 s at 12 to
6 years; p  0.001). An ST-segment elevation 1 mm
ccurred more often in carriers 5 years (5 to 8 years: p 
.09; 8 to 12 and 12 to 16 years: p 0.05; Table 1; Figs. 2B
nd 3). The ST-segment elevation was2 mm in 0%, 20%,
0%, and 80% of the children 5, 5 to 8, 8 to 12, and 12 to
6 years, respectively. There were no differences between
ale and female carriers in the aforementioned parameters,
ncluding QTc (boys, 0.44  0.06 s vs. girls 0.44  0.04 s;
ther data not shown) and ST-segment elevation.
olter. Above one year, mean and lowest HR in the
olter were mostly lower in carriers (Table 2). Highest HR
id not differ between the two groups (data not shown).
imilarly 1 year QT at HR 110 to 120 beats/min were
onger in carriers (Fig. 4). The QT after the longest pause
nd QT were longer in carriers (Table 2); QTc at the
owest HR for the whole group was longer in carriers than
n non-carriers (0.47  0.09 s vs. 0.36  0.03 s; p 
.0000). The differences in QT increase with age. Mean,
owest, and highest values of QTc at the lowest HR and of
QT in both groups are shown in Figure 5. A QTc of
0.44 at the lowest HR (sensitivity 100%; specificity
8.4%) and a QT 60 ms (sensitivity 100%; specificity




0–1 144  23 (7) 172  25 (6)*
1–3 117  28 (4) 127  23 (10)
3–5 88  9 (5) 102  20 (12)
5–8 82  13 (6) 90  13 (13)
8–12 74  19 (5) 82  15 (18)
12–16 69  14 (9) 79  12 (13)
RS width (ms)
Age (yrs)
0–1 49  11 45  8
1–3 73  16 57  13*
3–5 76  11 55  13*
5–8 82  20 64  11*
8–12 72  11 66  11









ean  SD (n). *p  0.05.
Carriers  with SNC5A gene mutation (1795insD); HR  heart rate; Non-
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July 19, 2005:331–7 Long QT3/Brugada Syndrome in Childrenlder than eight years of age had a QT 60 ms. Wenck-
bach block was seen more often in carriers than in
on-carriers (17.8% vs. 2.6%; p 0.05), but the difference
as not statistically significant in each age group owing to
he small numbers (Table 2). No difference was found in
hythm disturbances.
rgometry. There was no difference in highest HR (175
beats/min vs. 179  10 beats/min) and in QT at highest
igure 2. (A) QT interval for carriers (solid bars) and non-carriers (open
ars) in different age groups. (B) ST-segment elevation. Open bars for 0
o 1 year and solid bars for 1 to 3 years are not visible, because the values
re 0.0  0.0 mm. Mean  SD. *p  0.05.Figure 3. Electrocardiogram of a 12-year-old carrier showinR (0.23  0.10 s vs. 0.22  0.15 s) between carriers (n 
) and non-carriers (n  15). The QT at rest and during
xercise at HR 110 beats/min was longer in carriers than
n non-carriers. No ventricular arrhythmias occurred during
r after exercise.
AECG. The QRS width, D40, and V40 were higher,
onger, and lower, respectively, in carriers (Table 3).
ISCUSSION
he onset of various electrocardiographic phenomena of a
odium channel defect (SCN5A mutation 1795insD) in a
arge family showed age-dependent penetrance: QT-
rolongation and conduction defects are recognized from
irth onward and become more pronounced during ageing,
hereas right precordial ST-segment elevation becomes
rst apparent5 years. It is known that both LQT3 and BS
isplay age-dependent characteristics (8,9). In this family,
T prolongation is typically bradycardia-dependent and
orsens with increasing age. This concurs with the youngest
udden death in this family at 14 years of age, a typical age
or LQT3-related symptoms.
Right precordial ST-segment elevation, the hallmark of
S, was significantly more present in carriers 5 years and
ncreased further until 12 years. To the best of our knowl-
dge, there are no longitudinal studies on the electrocardio-
raphic characteristics of BS. Yet, it is well known that the
henotype is most often recognized in male patients in their
hird to fourth decade (10,11). These data concur with
significantly lower electrographic penetrance in children
ompared with adults with an SCN5A mutation (17% vs.
00%) (16).
Right precordial ST-segment elevation is thought to
esult from transmural inhomogeneity in action potential
AP) configuration in the RV wall. Loss of the epicardial
ome, among other potential consequences of a reduction in
odium-current amplitude, results in transmural current flow
rom endocardium to epicardium, picked up by the epicardial
eads as ST-segment elevation. The mutation identified in
his family significantly reduces sodium current by enhanc-
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Long QT3/Brugada Syndrome in Children July 19, 2005:331–7xpression of the mutant channel (unpublished data, C.
ezzina, July 2004). The contribution of the transient
utward current (Ito) is crucial to this sequence of events,
nd developmental changes in Ito amplitude have been
hown in canine epicardium (18). In dogs, Ito amplitude and
ensity change with age, thereby significantly influencing
he AP morphology of the epicardial AP in the first year of
ife. If similar changes occur in humans, it is well conceiv-
ble that the gradual increase in ST-segment amplitude is
aused by a gradual age-dependent increase in epicardial Ito
urrent. In the presence of reduced sodium current, an
ncrease in Ito might eventually lead to loss of the epicardial
lateau phase. Alternatively, an age-dependent reduction in
odium current might be present. The age-dependent in-
rease in QRS width (Table 1) might reflect this. It has also
een shown that, in adults, ageing impacts on conduction
lowing in SCN5A mutant carriers (19).
The gradual increase in QT prolongation is less well
xplained. For this mutation, QT prolongation results from
nhanced persistent sodium current (6). It is difficult, if not
mpossible, to predict the effect that age-dependent alter-
tion in ion currents, including Ito, has on AP-duration.
ence, a good explanation is not readily available. Gender-
pecific differences were not observed; this may be explained
y the small hormonal differences in prepubertal children.
Although none of the children with LQT3 in this family
ad any complaints, LQT3 can be a serious illness with
udden death as first manifestation (8). Whether ventricular




0–1 127  14
1–3 105  12
3–5 88  4 (5
5–8 86  6 (3
8–12 75  8 (8
12–16 70  7 (8
QT (ms) after pau
Age (yrs)
0–1 350  43
1–3 430  48
3–5 508  42
5–8 567  50
8–12 630  55
12–16 670  107








Mean  SD (n). *p  0.05.
QT  QT interval; other abbreviations as in Table 1.rrhythmias or conduction disturbances are responsible for uudden death in this family is not known yet. In two
ymptomatic adults of this family, progressive cardiac con-
uction disturbance and prolonged asystole were found,
hich raises the possibility of a bradycardic mode of death (7).
n the children, more Wenckebach block at night in the
arriers was found. This is a very special phenomenon,
ecause it is normally only seen at ages 9 years. Further-
ore, it may be a serious triggering event for death, because
f the provoking bradycardia and associated QT prolonga-
ion. Although the phenotype of the SCN5A mutation in
he family evaluated is already present at very young age, the
oungest child that died was 14 years old; however, other
CN5A mutations have been described as leading to sudden
nfant death syndrome (SIDS) or near-SIDS (20–23).
Before the mutation was detected in this family, we
ollowed the children clinically and only treated them with
acemaker implantation when there were signs of extreme
radycardia or QT prolongation after pauses during the
ight. But because serious events in LQT3 can manifest in
eonates, and because the results of our study demonstrate
he occurrence of nocturnal bradycardias and QT prolon-
ation even in the youngest children, the age at which the
hildren should be treated with pacemaker implantation is
uestionable.
The adults in this family were prophylactically treated
ith an anti-bradycardia pacemaker as a preventive measure
gainst sudden death. In adults, this strategy proved to be
ffective, because there were no more cases of sudden
iers Non-Carriers
Lowest Mean Lowest
72  7 131  22 (2) 80  5
60  8 119  12 (9)* 77  12*
51  3 106  22 (9)* 67  16*
50  4 94  7 (11) 63  10*
43  5 84  8 (19)* 52  7*
40  4 82  7 (17)* 49  5*
QT after pause QT
23  15 300  28 20  8
45  38 329  36* 9  15*
56  17 350  45* 13  15*
60  40 376  21* 10  14*
90  25 397  25* 14  15*
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July 19, 2005:331–7 Long QT3/Brugada Syndrome in Childrenacemaker (n  30), while five sudden deaths occurred
mong the remaining 30 carriers without a pacemaker (7).
herefore, it is our policy now to insert anti-bradycardia
acemakers in the children as well, partly because the first
ymptom is nocturnal death and partly because of the anxiety
f the parents. None of the children with a pacemaker died.
igure 4. Relation between heart rate and QT interval for carriers (solid
p  0.05. bpm  beats per minute.e therefore consider implantable cardioverter-defibrillator eherapy, which could be considered even in small children
7,10,24), not necessary. Beta-blockers seem less effective in
QT3 patients (9), and with flecainide, clear augmentation of
T-segment elevation has been observed (25).
Our study demonstrates that LQT3 can be diagnosed
ith clinical tools at very young age in this family. The
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Long QT3/Brugada Syndrome in Children July 19, 2005:331–7erform genetic analysis, because the mutation is known.
ut for other families in which a mutation has not been
dentified yet, it is useful to know which clinical tools
ontribute to the diagnosis of LQT3 at young age. Good
linical parameters for this diagnosis are the QT on an
CG, the QT, QTc and QT in a Holter, especially when
ocusing on the low HR at night and after pauses. Ergom-
try does not contribute to the diagnosis.
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